Skip to main content
SSY Group Limited logo

SSY Group Limited — Investor Relations & Filings

Ticker · 2005 ISIN · KYG8406X1034 HKEX Manufacturing
Open in API
Filings indexed 1,213 across all filing types
Latest filing 2022-08-29 Interim / Quarterly Rep…
Country HK Hong Kong
Listing HKEX 2005

About SSY Group Limited

http://www.ssygroup.com.hk

SSY Group Limited is an investment holding company specializing in the research, development, manufacturing, and sale of pharmaceutical products. The Group is a prominent manufacturer, with a core focus on producing a wide range of intravenous infusion solutions and finished drugs. Complementing its pharmaceutical offerings, the company also manufactures essential packaging materials, including non-PVC soft bags and PP plastic containers. SSY Group supplies its comprehensive product line, which often utilizes green production technologies aimed at reducing costs and power consumption, primarily to hospitals and medical institutions.

Recent filings

Filing Released Lang Actions
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2022
Interim / Quarterly Report Classification · 95% confidence The document is titled 'ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2022' and contains detailed financial and operational data for the six-month period ending June 30, 2022. It includes revenue figures, profit, dividend distribution, business review, sales data, and product performance. The content is comprehensive and covers substantive financial data and analysis for a period shorter than a full fiscal year. This matches the definition of an Interim / Quarterly Report (IR). The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement or publication notice. Therefore, the correct classification is IR with high confidence. H1 2022
2022-08-29 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 95% confidence The document is a short announcement from SSY Group Limited stating the date of a Board meeting to approve and publish the unaudited interim results for the six months ended 30 June 2022. It also mentions consideration of an interim dividend. The document does not contain any financial data or the actual interim report but only announces the upcoming board meeting and the intention to release the interim results. The length is only 1366 characters, which is very short and fits the pattern of an announcement rather than a full report. According to the rules, such announcements about the timing or intention to publish a report are classified as Report Publication Announcements (RPA).
2022-08-17 English
POSITIVE PROFIT ALERT
Capital/Financing Update Classification · 95% confidence The document is titled 'POSITIVE PROFIT ALERT' and is an announcement made pursuant to the Listing Rules and Inside Information Provisions of the Hong Kong Stock Exchange. It provides a preliminary review of unaudited consolidated management accounts for the six months ended 30 June 2022, indicating a significant expected increase in profit. The document explicitly states that the information is based on unaudited accounts and that the final consolidated interim results will be published later. The document is relatively short (4451 characters) and serves as an alert or preliminary announcement rather than a full interim report containing detailed financial statements or substantive financial data. Therefore, it is not an Interim/Quarterly Report (IR) but rather a Capital/Financing Update (CAP) or Earnings Release (ER). However, since it is a profit alert based on preliminary unaudited results and not a formal earnings release with key highlights, the best fit is Capital/Financing Update (CAP), which covers updates on company financial performance before formal results are published.
2022-08-01 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return regarding movements in securities, specifically focusing on authorized and issued shares, share options, and confirmations related to securities issued by the issuer. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with listing rules. The content is regulatory in nature, providing updates on share capital and share issuance movements rather than a financial report or earnings release. It does not contain financial statements or management discussion but is a regulatory submission about share capital movements. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-08-01 English
VOLUNTARY ANNOUNCEMENT - SELECTION RESULTS OF NATIONAL CENTRALIZED MEDICINES PROCUREMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by the company's board regarding the results of a national centralized medicines procurement tender. It provides information about product awards and expected business impact but does not contain financial statements, detailed financial analysis, or regulatory filings. The document is relatively short (2289 characters) and serves to inform shareholders and investors about a business development rather than reporting financial results or governance changes. It is not an annual or interim report, audit report, earnings release, or any other detailed financial or regulatory filing. It is also not a voting result, management change, or capital update. Therefore, it fits best as a general regulatory announcement about business developments, which falls under Regulatory Filings (RNS).
2022-07-13 English
QUOTATION OF JIANGSU BEST NEW MEDICAL ON THE NEEQ
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the quotation of shares of Jiangsu Best New Medical on the National Equities Exchange and Quotations (NEEQ). It discusses the completion of a placing of new shares, including details about connected and non-connected placings, and the implications under the Listing Rules. The document is relatively short (3598 characters) and serves as a notification of a capital market event rather than a detailed financial report or presentation. It does not contain financial statements or detailed analysis but rather informs about a financing activity and share placement. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2022-07-06 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.